Abstract
New prostaglandins analogues, containing heteroatoms in the cyclopentane ring were synthesized. The key step in the synthesis was the preparation of the five-membered ring starting from L-cysteine ethyl ester hydrochloride. The addition of the alkyl groups at C-15 position was also performed.
Keywords: Heterocyclic prostaglandins, azaprostaglandins, thiaprostaglandins
Letters in Organic Chemistry
Title: Synthesis of Novel Heterocyclic Prostaglandin Analogues
Volume: 4 Issue: 1
Author(s): Francisco C. Biaggio, Alessandra R. Rufino and Marcela C.F. Silveira
Affiliation:
Keywords: Heterocyclic prostaglandins, azaprostaglandins, thiaprostaglandins
Abstract: New prostaglandins analogues, containing heteroatoms in the cyclopentane ring were synthesized. The key step in the synthesis was the preparation of the five-membered ring starting from L-cysteine ethyl ester hydrochloride. The addition of the alkyl groups at C-15 position was also performed.
Export Options
About this article
Cite this article as:
Biaggio C. Francisco, Rufino R. Alessandra and Silveira C.F. Marcela, Synthesis of Novel Heterocyclic Prostaglandin Analogues, Letters in Organic Chemistry 2007; 4 (1) . https://dx.doi.org/10.2174/157017807780037388
DOI https://dx.doi.org/10.2174/157017807780037388 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Inhaled Biologicals for the Treatment of Cystic Fibrosis
Recent Patents on Inflammation & Allergy Drug Discovery Airway Smooth Muscle Cell as Therapeutic Target of Inflammation
Current Medicinal Chemistry Snake Venom Induced Local Toxicities: Plant Secondary Metabolites as an Auxiliary Therapy
Mini-Reviews in Medicinal Chemistry Adjuvant Therapies of COVID-19 - A Literature Review
Coronaviruses Pharmacognostical Overview of “Gunma Kuligai” – a Traditional Siddha Preparation for Treating Acid Peptic Disease (APD)
Current Traditional Medicine Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
Current Pharmaceutical Design PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling
Recent Patents on CNS Drug Discovery (Discontinued) Phytohormone Crosstalk Research: Cytokinin and its Crosstalk with Other Phytohormones
Current Protein & Peptide Science Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion
Current Pharmaceutical Design Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors
Current Medicinal Chemistry Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features
Current Neurovascular Research Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Recent Patents in Pemphigus Research, Prophylaxis, Diagnosis and Treatment in USA (1988-2006)
Recent Patents on Inflammation & Allergy Drug Discovery Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry Lymphoid-Specific Tyrosine Phosphatase (Lyp): A Potential Drug Target For Treatment of Autoimmune Diseases
Current Drug Targets Lectin Microarrays: A Powerful Tool for Glycan-Based Biomarker Discovery
Combinatorial Chemistry & High Throughput Screening Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology A Point of View: The Need to Identify an Antigen in Psyconeuroimmunological Disorders
Current Pharmaceutical Design